Home > Financial Ratios > SOTAC PHARMACEUTICALS

SOTAC PHARMACEUTICALS
EBIT Margin

    Back to All Ratios
AD     Remove this Ad

SOTAC PHARMACEUTICALS Last 5 Year EBIT Margin History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EBIT Margin(%) 14.135.497.707.20-2.11

What is the latest EBIT Margin ratio of SOTAC PHARMACEUTICALS ?

The latest EBIT Margin ratio of SOTAC PHARMACEUTICALS is 14.13 based on Mar2025 Consolidated results.
Year EBIT Margin
Mar202514.13
Mar20245.49
Mar20237.70
Mar20227.20
Mar2021-2.11

How is EBIT Margin of SOTAC PHARMACEUTICALS Trending?

Years EBIT Margin % Change
Mar2025 14.13
157.38
Mar2024 5.49
-28.70
Mar2023 7.7
6.94
Mar2022 7.2
Positive
Mar2021 -2.11 -

Other Financial Ratios of SOTAC PHARMACEUTICALS


Compare EBIT Margin ratio of peers of SOTAC PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS ₹131.8 Cr 5.2% -7.3% -0.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹413,717.0 Cr 0.6% 7% 1.4% Stock Analytics
DIVIS LABORATORIES ₹166,830.0 Cr 1.6% 4.6% 3.7% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,479.0 Cr 3.1% 5.9% 39% Stock Analytics
CIPLA ₹108,978.0 Cr 1.5% -2.1% -7.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,905.0 Cr 0.5% 9.8% 5.7% Stock Analytics


SOTAC PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SOTAC PHARMACEUTICALS

5.2%

-7.3%

-0.8%

SENSEX

-0.6%

0.6%

9.8%


You may also like the below Video Courses